Необходимый минимум данных в направлении на морфологическое исследование и в заключении морфолога при раке легкого: рекомендации для клиницистов и патологов (патологоанатомов и цитопатологов)

Велижева Надежда Павловна, Дардык Мария Вениаминовна, Эскарио Мария Долорес Лозано et al. · Вестник РОНЦ им. Н. Н. Блохина РАМН · 2013

Discovery of specific molecular alterations that are involved in the pathophysiologic mechanisms of lung carcinoma resulted in the development of new-targeted drugs, which are effective in patients with specific histological types of non-small cell lung carcinoma (NSClC). False or inaccurate morphological diagnosis can lead to the prescription of ineffective therapy (including targeted) or can cause serious side effects in case of the incorrect drug usage. Considering that a vast majority of lung cancers are diagnosed in advanced clinical stages, pathologic diagnostics based on small biopsy material or cytologic samples is highly important thereby being minimally invasive in inoperable patients. Eurasian Federation of Oncology gathered a working group of experts, consisting of pathologists and clinicians, which has developed a unified pathology request form, containing the very minimum essential informationapathologist needs fromaclinician, andaunified template for pathology reporting of lung cancer that complies with the present understanding of lung cancer diagnostics and treatment.

Cited by 0 works.

Authors